Zhai et al. used NSG-SGM3-BLT humanized mice that were intracranially implanted with patient GBM xenografts to study the intratumoral expression of IDO1, an enzyme that is implicated in cancer-related immunosuppression. The gene discussed is IDO1; the disease is glioblastoma.